Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients

Title
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Authors
Keywords
-
Journal
ONCOLOGIST
Volume 22, Issue 1, Pages 25-32
Publisher
Alphamed Press
Online
2016-10-28
DOI
10.1634/theoncologist.2016-0229

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search